First-in-human trial for new lung cancer immunotherapy
Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.
Dec 19, 2019
0
598